Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
Another provider on our semaglutide provider ranking.
Read the SnagRx review →
Provider review
A genuinely flat $99 — attached to drugs that have no lawful compounding path.
Its pricing is the most honest here: one rate, no bundles, no savings claims. It also sells retatrutide at $399/mo under a blanket claim that everything it ships "meets federal quality and safety standards."
By Marcus Webb
Transparency scorecard
3 of 4 disclosed openly
What Pepti discloses about itself, read from its own pages — not estimated.
Pharmacy category stated
Not disclosed
Names its pharmacies but states no federal regulatory category (503A/503B) for them on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Disclosed
The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. A commission does not change what a review says. Full disclosure here.
At a glance
Visit PeptiPharmacy
Not categorized
Labs
Not published as a requirement, cost or cadence.
States
Published state list
Also on this list

SnagRx
$69 semaglutide and $119 tirzepatide "locked in for life," but every payment is final.
Another provider on our semaglutide provider ranking.
Read the SnagRx review →What this price covers
Medication
Included
Provider visits
Not confirmed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
Prices read from Pepti's own site
What they advertise
A flat $99/mo for compounded semaglutide, stated in its own FAQ as "flat and transparent at $99/mo all-in." Tirzepatide $199, sermorelin $189, PT-141 $199, NAD+ $179, glutathione $129, GHK-Cu $239. One-time purchase is a flat 1.25x the subscription price.
What you actually pay
$99/mo compounded semaglutide, $199/mo tirzepatide, $189/mo sermorelin, $199/mo PT-141, $179/mo NAD+, $129/mo glutathione, $239/mo GHK-Cu. These are standing rates: the pages carry no first-month, intro or promotional split anywhere.
Money you will meet later
Pepti has the cleanest pricing on this site. Compounded semaglutide is a flat $99 a month — its own FAQ says "we keep pricing flat and transparent at $99/mo all-in" — with tirzepatide at $199, sermorelin $189, PT-141 $199, NAD+ $179, glutathione $129 and GHK-Cu $239. There are exactly two tiers, subscription or a one-time purchase at 1.25 times the price, so there are no bundles and no savings claims for arithmetic to contradict. Billing is calendar-monthly, cancellation is self-serve, and a price change requires 30 days' notice. It names Olympia Pharmacy and enumerates 36 states. The problem is what else is in the catalog: retatrutide, melanotan II, tesofensine and others, all sold under one blanket assurance of federal compliance that none of them can actually satisfy.
Pepti appears on our semaglutide provider ranking and our combined weight loss injections ranking.
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Pepti names the pharmacies that may fill your prescription, but states no regulatory category for them.
Named, but hidden. Its own pages name Olympia Pharmacy as the fulfilling pharmacy — on a legal page that is absent from its own sitemap, so a reader is unlikely to find it.
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
36 states, fully enumerated on its own pages, and corroborated by its own per-state URL space, which matches that list exactly.
The part they would rather you skipped
Pepti sells retatrutide at $399 a month. Retatrutide is an investigational drug: it has no approved reference product, no USP monograph, and it does not appear on FDA's 503A bulk substances list, so there is no lawful route by which a 503A or 503B pharmacy can compound it. Pepti nonetheless covers its entire catalog with a single assurance that its products are "compounded at FDA-registered 503A/503B pharmacies" and "meet federal quality and safety standards." That sentence is doing work it cannot do, and retatrutide is not the only item relying on it — melanotan II, tesofensine, epithalon, SS-31 and 5-amino-1MQ sit under the same blanket. Underneath it, two physicians, licensed in 26 and 15 states respectively, cover 36 states and 123 products between them.
Other providers on our semaglutide provider ranking — the closest match to what Pepti sells.






174 more providers are on our semaglutide provider ranking — see the full list. Every provider we review →
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Pepti's current pricing before you decide. Ours was read from their own site.
Facts on this page reflect Pepti's own public disclosures when we last checked them. Prices and terms change without notice — confirm on Pepti's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Pepti
$99/mo · Semaglutide